Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting133%
not_yet_recruiting267%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingearly_phase_1

Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)

NCT07197021
recruiting

TEER for Severe DMR of Low to Intermediate Surgery Risk

NCT06162780
not_yet_recruitingnot_applicable

Edge-to-edge Mitral Valve Repair in ATTR-CM

NCT06075823

Clinical Trials (3)

Showing 3 of 3 trials
NCT07197021Early Phase 1

Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)

Not Yet Recruiting
NCT06162780

TEER for Severe DMR of Low to Intermediate Surgery Risk

Recruiting
NCT06075823Not Applicable

Edge-to-edge Mitral Valve Repair in ATTR-CM

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3